Brussels-based Wooclap secures €25M to expand its interactive learning platform…
Brussels-based edtech company Wooclap secures new funding to expand its interactive learning platform for higher education and corporate training.
Technology, AI, capital and institutions, examined through who builds systems, who controls them and who benefits.
11,488 articles · Technology & Power
Brussels-based edtech company Wooclap secures new funding to expand its interactive learning platform for higher education and corporate training.
Espoo-based IQM Quantum Computer, a company specialised in full-stack superconducting quantum computers, has raised €275M in a Series B funding round, bringing the total funding raised to date to $600M (approximately €514M).
Stockholm-based Aonic, a group of multiplatform tech and gaming companies, announced the acquisition of research technology firm Prime Insights for a total transaction value of over $250M (approximately €214M).
Cambridge-based Xampla, a creator of natural materials for commercial applications, has secured $14M (approximately €12M) in a Series A funding round.
ViCentra, maker of the Kaleido insulin patch pump, has closed a Series D funding round from new and existing investors.
A new euro-denominated Bitcoin company, Treasury, launches with initial funding with plans to list on a European stock exchange.
Paris-based ArcaScience, the AI healthtech startup, has raised $7M (approximately €6M) in a seed funding round led by The Moon Venture, with participation from Pléiade Venture, Plug&Play Ventures, Bpifrance, and AKKA Technologies.
In the heart of Eastern Germany, a quiet revolution has been brewing.
Anthropic has raised new funding in a Series F round, bringing its valuation to €157.19B. The company looks to expand its work in AI systems and research.
Vienna-based Econetix, a climate tech startup, has raised €4.5M in seed funding to accelerate its expansion across the DACH region, the Middle East, and Africa.
Munich-based Tangany, a BaFin-regulated digital asset custodian, has secured €10M in a Series A funding round.
Finnish/Dutch biotechnology company Arivin Therapeutics secures funding to develop therapies for drug-resistant bacterial infections and more.